Meiji Yasuda Asset Management Co Ltd. Raises Position in Henry Schein, Inc. (HSIC)
Meiji Yasuda Asset Management Co Ltd. boosted its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 95.2% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 12,212 shares of the company’s stock after purchasing an additional 5,956 shares during the quarter. Meiji Yasuda Asset Management Co Ltd.’s holdings in Henry Schein were worth $1,001,000 at the end of the most recent reporting period.
Other hedge funds have also recently made changes to their positions in the company. YorkBridge Wealth Partners LLC grew its position in Henry Schein by 5.2% during the 2nd quarter. YorkBridge Wealth Partners LLC now owns 570 shares of the company’s stock valued at $104,000 after purchasing an additional 28 shares during the last quarter. Sun Life Financial INC grew its position in Henry Schein by 8,185.7% during the 2nd quarter. Sun Life Financial INC now owns 580 shares of the company’s stock valued at $106,000 after purchasing an additional 573 shares during the last quarter. Trust Co. of Vermont grew its position in Henry Schein by 56.7% during the 3rd quarter. Trust Co. of Vermont now owns 1,702 shares of the company’s stock valued at $140,000 after purchasing an additional 616 shares during the last quarter. Lee Financial Co grew its position in Henry Schein by 100.0% during the 3rd quarter. Lee Financial Co now owns 1,756 shares of the company’s stock valued at $144,000 after purchasing an additional 878 shares during the last quarter. Finally, Benjamin F. Edwards & Company Inc. grew its position in Henry Schein by 281.8% during the 3rd quarter. Benjamin F. Edwards & Company Inc. now owns 2,100 shares of the company’s stock valued at $172,000 after purchasing an additional 1,550 shares during the last quarter. 63.60% of the stock is currently owned by institutional investors.
HSIC has been the topic of several recent analyst reports. BidaskClub downgraded shares of Henry Schein from a “hold” rating to a “sell” rating in a research report on Wednesday, August 2nd. Northcoast Research raised shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $109.00 price objective on the stock in a research report on Monday, August 7th. Zacks Investment Research downgraded shares of Henry Schein from a “buy” rating to a “hold” rating in a research report on Wednesday, August 9th. Credit Suisse Group reissued a “hold” rating and set a $87.50 price objective on shares of Henry Schein in a research report on Tuesday, August 29th. Finally, Piper Jaffray Companies raised shares of Henry Schein from a “neutral” rating to an “overweight” rating in a research report on Friday, September 15th. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and seven have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $89.88.
COPYRIGHT VIOLATION WARNING: This piece of content was posted by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of international copyright laws. The legal version of this piece of content can be accessed at https://www.watchlistnews.com/meiji-yasuda-asset-management-co-ltd-raises-position-in-henry-schein-inc-hsic/1719880.html.
Shares of Henry Schein, Inc. (HSIC) traded up $0.47 during midday trading on Wednesday, hitting $67.97. 2,848,000 shares of the stock were exchanged, compared to its average volume of 1,177,270. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.86 and a current ratio of 1.55. The stock has a market cap of $10,670.00, a P/E ratio of 18.93, a PEG ratio of 1.90 and a beta of 1.03. Henry Schein, Inc. has a 12-month low of $65.28 and a 12-month high of $93.50.
Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Monday, November 6th. The company reported $0.87 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.90 by ($0.03). The business had revenue of $3.16 billion during the quarter, compared to analysts’ expectations of $3.05 billion. Henry Schein had a return on equity of 19.71% and a net margin of 4.52%. The business’s quarterly revenue was up 10.3% compared to the same quarter last year. During the same period in the previous year, the business posted $0.84 EPS. equities research analysts forecast that Henry Schein, Inc. will post 3.6 EPS for the current fiscal year.
Henry Schein declared that its board has initiated a share repurchase program on Monday, September 18th that allows the company to repurchase $400.00 million in outstanding shares. This repurchase authorization allows the company to buy up to 6.3% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company’s management believes its stock is undervalued.
In related news, SVP Paul Rose sold 2,126 shares of the firm’s stock in a transaction that occurred on Wednesday, September 6th. The shares were sold at an average price of $172.51, for a total value of $366,756.26. Following the transaction, the senior vice president now owns 17,841 shares of the company’s stock, valued at $3,077,750.91. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 1.19% of the company’s stock.
Henry Schein Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.